NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0600
0.00 (0.00%)
At close: Jan 15, 2026
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $7.46 million as of January 20, 2026. Its market cap has decreased by -33.80% in one year.
Market Cap
7.46M
Enterprise Value
60.26M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 7.46M, a decrease of -97.79%. That is a compound annual growth rate of -78.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 7.46M | 20.00% |
| Dec 31, 2025 | 6.22M | -73.65% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |